只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-07-09 2026-07-13 | BBIO BridgeBio Pharma, Inc. | Ellis Andrea Director | 卖出（S） | 17,167 | US$84.00 | US$144.2万 | 22,579 | SEC |
| 2026-06-24 2026-06-24 | BBIO BridgeBio Pharma, Inc. | Cook Jennifer E. Director | 卖出（S） | 37,167 | US$70.00 | US$260.17万 | 8,383 | SEC |
| 2026-06-23 2026-06-24 | BBIO BridgeBio Pharma, Inc. | Valantine Hannah Director | 卖出（S） | 2,196 | US$68.57 | US$150,579.72 | 9,259 | SEC |
| 2026-06-23 2026-06-24 | BBIO BridgeBio Pharma, Inc. | Cook Jennifer E. Director | 卖出（S） | 2,196 | US$68.57 | US$150,579.72 | 8,383 | SEC |
| 2026-06-22 2026-06-24 | BBIO BridgeBio Pharma, Inc. | Valantine Hannah Director | 卖出（S） | 2,808 | US$68.00 | US$190,944.00 | 11,455 | SEC |
| 2026-06-15 2026-06-17 | BBIO BridgeBio Pharma, Inc. | Cook Jennifer E. Director | 卖出（S） | 1,503 | US$67.14 | US$100,911.42 | 6,589 | SEC |
| 2026-06-15 2026-06-17 | BBIO BridgeBio Pharma, Inc. | Cook Jennifer E. Director | 卖出（S） | 88,737 | US$66.62 | US$591.17万 | 8,092 | SEC |
| 2026-06-05 2026-06-08 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 7,147 | US$67.20 | US$480,278.40 | 528,539 | SEC |
| 2026-06-05 2026-06-08 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 4,415 | US$68.96 | US$304,458.40 | 4,318,447 | SEC |
| 2026-06-05 2026-06-08 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 4,416 | US$68.96 | US$304,527.36 | 515,686 | SEC |
| 2026-06-05 2026-06-08 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 8,437 | US$67.88 | US$572,703.56 | 520,102 | SEC |
| 2026-06-05 2026-06-08 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 8,437 | US$67.88 | US$572,703.56 | 4,322,862 | SEC |
| 2026-06-05 2026-06-08 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 7,148 | US$67.20 | US$480,345.60 | 4,331,299 | SEC |
| 2026-06-04 2026-06-08 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 2,200 | US$65.72 | US$144,584.00 | 553,486 | SEC |
| 2026-06-04 2026-06-08 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 1,429 | US$66.72 | US$95,342.88 | 552,057 | SEC |
| 2026-06-04 2026-06-08 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 15,921 | US$67.74 | US$107.85万 | 536,136 | SEC |
| 2026-06-04 2026-06-08 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 450 | US$68.27 | US$30,721.50 | 535,686 | SEC |
| 2026-06-04 2026-06-08 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 2,200 | US$65.72 | US$144,584.00 | 4,356,247 | SEC |
| 2026-06-04 2026-06-08 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 1,429 | US$66.72 | US$95,342.88 | 4,354,818 | SEC |
| 2026-06-04 2026-06-08 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 15,921 | US$67.74 | US$107.85万 | 4,338,897 | SEC |
| 2026-06-04 2026-06-08 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 450 | US$68.27 | US$30,721.50 | 4,338,447 | SEC |
| 2026-05-21 2026-05-26 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 800 | US$70.92 | US$56,736.00 | 243,327 | SEC |
| 2026-05-21 2026-05-26 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 2,256 | US$67.57 | US$152,437.92 | 267,174 | SEC |
| 2026-05-21 2026-05-26 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 6,725 | US$68.30 | US$459,317.50 | 260,449 | SEC |
| 2026-05-21 2026-05-26 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 5,072 | US$69.22 | US$351,083.84 | 255,377 | SEC |
| 2026-05-21 2026-05-26 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 11,250 | US$70.48 | US$792,900.00 | 244,127 | SEC |
| 2026-05-18 2026-05-19 | BBIO BridgeBio Pharma, Inc. | Trimarchi Thomas Officer · President and CFO | 卖出（S） | 10,456 | US$64.82 | US$677,757.92 | 362,389 | SEC |
| 2026-05-18 2026-05-19 | BBIO BridgeBio Pharma, Inc. | Trimarchi Thomas Officer · President and CFO | 卖出（S） | 3,195 | US$65.95 | US$210,710.25 | 359,194 | SEC |
| 2026-05-15 2026-05-19 | BBIO BridgeBio Pharma, Inc. | Scott Randal W. Director | 卖出（S） | 200 | US$69.12 | US$13,824.00 | 11,589 | SEC |
| 2026-05-15 2026-05-19 | BBIO BridgeBio Pharma, Inc. | Scott Randal W. Director | 卖出（S） | 2,088 | US$67.53 | US$141,002.64 | 13,301 | SEC |
| 2026-05-15 2026-05-19 | BBIO BridgeBio Pharma, Inc. | Scott Randal W. Director | 卖出（S） | 1,512 | US$68.23 | US$103,163.76 | 11,789 | SEC |
| 2026-05-15 2026-05-19 | BBIO BridgeBio Pharma, Inc. | Scott Randal W. Director | 卖出（S） | 6,200 | US$66.69 | US$413,478.00 | 15,389 | SEC |
| 2026-05-08 2026-05-11 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 13,973 | US$66.65 | US$931,300.45 | 561,713 | SEC |
| 2026-05-08 2026-05-11 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 5,077 | US$67.35 | US$341,935.95 | 556,636 | SEC |
| 2026-05-08 2026-05-11 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 950 | US$68.35 | US$64,932.50 | 555,686 | SEC |
| 2026-05-08 2026-05-11 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 13,974 | US$66.65 | US$931,367.10 | 4,364,473 | SEC |
| 2026-05-08 2026-05-11 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 5,076 | US$67.35 | US$341,868.60 | 4,359,397 | SEC |
| 2026-05-08 2026-05-11 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 950 | US$68.35 | US$64,932.50 | 4,358,447 | SEC |
| 2026-05-07 2026-05-11 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 8,333 | US$68.38 | US$569,810.54 | 576,136 | SEC |
| 2026-05-07 2026-05-11 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 450 | US$69.09 | US$31,090.50 | 575,686 | SEC |
| 2026-05-07 2026-05-11 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 11,217 | US$67.49 | US$757,035.33 | 4,387,230 | SEC |
| 2026-05-07 2026-05-11 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 8,334 | US$68.38 | US$569,878.92 | 4,378,896 | SEC |
| 2026-05-07 2026-05-11 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 11,217 | US$67.50 | US$757,147.50 | 584,469 | SEC |
| 2026-05-07 2026-05-11 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 449 | US$69.09 | US$31,021.41 | 4,378,447 | SEC |
| 2026-04-30 2026-05-04 | BBIO BridgeBio Pharma, Inc. | Apuli Maricel Officer · Chief Accounting Officer | 卖出（S） | 2,000 | US$71.58 | US$143,160.00 | 134,115 | SEC |
| 2026-04-10 2026-04-13 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 20,000 | US$74.60 | US$149.2万 | 4,398,447 | SEC |
| 2026-04-10 2026-04-13 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 20,000 | US$74.60 | US$149.2万 | 595,686 | SEC |
| 2026-04-09 2026-04-13 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 7,200 | US$73.64 | US$530,208.00 | 628,486 | SEC |
| 2026-04-09 2026-04-13 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 7,800 | US$75.53 | US$589,134.00 | 4,418,447 | SEC |
| 2026-04-09 2026-04-13 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 5,128 | US$74.57 | US$382,394.96 | 4,426,247 | SEC |
| 2026-04-09 2026-04-13 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 7,072 | US$73.64 | US$520,782.08 | 4,431,375 | SEC |
| 2026-04-09 2026-04-13 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 7,500 | US$75.55 | US$566,625.00 | 615,686 | SEC |
| 2026-04-09 2026-04-13 | BBIO BridgeBio Pharma, Inc. | Kumar Neil Director,Officer · Chief Executive Officer | 卖出（S） | 5,300 | US$74.60 | US$395,380.00 | 623,186 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| BBIO | 733,794.0004 | 16,314 | 1,079,575.058 | 67.97% | B, Q, N |